Dermatomyositis-like reaction induced by chemotherapeutical agents

International Journal of Dermatology

Volumn 41, Issue 12, 2002, Pages 885-887

  Ruiz Genao, Diana P ^a   Sanz Sachez T ^a   Bartolome Gonzalez B ^a   Fernandez Herrera J ^a   Garci Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MUSCLE ENZYME;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; BASAL CELL; CANCER CHEMOTHERAPY; CASE REPORT; CELL DEGENERATION; CELL INFILTRATION; CHEEK; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DERMATOMYOSITIS; DRUG MEGADOSE; ELBOW DISEASE; ERYTHEMA; EYELID DISEASE; EYELID EDEMA; FEMALE; FINGER; FOLLICULAR LYMPHOMA; FOREHEAD; GRAFT VERSUS HOST REACTION; HAND DISEASE; HAND PALM; HUMAN; HYPERKERATOSIS; IMMUNOSUPPRESSIVE TREATMENT; INTERPHALANGEAL JOINT; KERATINOCYTE; MALE; MUSCLE WEAKNESS; NAILFOLD DISEASE; SKIN DISEASE; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; ETOPOSIDE; FEMALE; HUMANS; HYDROXYUREA; MALE;

EID: 0036942517     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01349.x     Document Type: Conference Paper

References (13)

1. Dourmishev AL, Dourmishev LA. Dermatomyositis and drugs. Adv Exp Med Biol 1999; 455: 187-191.
2. Rios-Buceta L, Buezo GF, Peñas PF, et al. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with tegafur. Acta Derm Venereol 1996; 77: 80-81.
3. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea treatment. Arch Dermatol 1975; 111: 183-187.
4. Sigal M, Crickx B, Blanchet P, et al. Lesions cutanées induites par l'utilisation au long cours de l'hydroxyurée. Ann Dermatol Venereol 1984; 11: 895-900.
5. Richards M, Truchetet F, Friedel J, et al. Skin lesions simmulating chronic dermatomyositis during long-term hydroxyurea therapy. J Am Acad Dermatol 1989; 21: 797-799.
6. Kelly RI, Bull RH, Marsden A. Cutaneous manifestations of long-term hydroxyurea therapy. Australas J Dermatol 1994; 35: 61-64.
7. Senet P, Aractingi S, Porneuf M, et al. Hydroxyurea-induced dermatomyositis-like eruption. Br J Dermatol 1995; 133: 455-459.
8. Bahadoran P, Castanet J, Lacour J. Pseudo-dermatomyositis induced by long-term hydroxyurea therapy. Report of two cases. Br J Dermatol 1996; 134: 1151-1165.
9. Suehiro M, Kishimoto S, Wakabayashi T. Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer. Br J Dermatol; 139: 748-749, 1998.
10. Vélez A, López-Rubio F, Moreno JC. Chronic hydroxyurea-induced dermatomyositis-like eruption with severe dermal elastosis. Clin Exp Dermatol 1998; 23: 92-96.
11. Akiyama C, Osada A, Sou K, et al. A case of dermatomyositis triggered by tegafur. Acta Derm Venereol 1997; 77: 490.
12. Carroll GJ, Will RK, Peter JB, et al. Penicillamine induced polimyositis and dermatomyositis. J Rheumatol 1987; 14: 995-1001.
13. Simpson NB, Golding JR. Dermatomyositis induced by penicillamine. Acta Derm Venereol; 59: 543-544, 1979.